Classen JB, Classen DC. 1999. Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity. 31:43–45.
Communicable Disease Report. 2001. MMR vaccination coverage in the United Kingdom. Communicable Disease Report CDR Weekly. 11(4).
Constantinescu CS, Wysocka M, Milliard B, Ventura ES, Lavi E, Trinchieri G, Rostami A. 1998. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol. 161:5097–5104.
Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 13:470–511.
Dagan R, Eskola J, Leclerc C, Leroy O. 1998. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 66(5):2093–2098.
Dahlquist G, Gothefors L. 1995. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia. 38:873–874.
Daniel T, Bates JH, Downes K. 1994. History of Tuberculosis. Bloom BR, ed. Tuberculosis: Pathogenesis, Protection, and Control.Washington, DC: ASM Press. Pp. 13–24.
Davidson A, Diamond B. 2001. Autoimmune diseases. N Engl J Med. 345:340–350.
Davidson M, Letson GW, Ward JI, Ball A, Bulkow L, Christenson P, Cherry JD. 1991. DTP immunization and susceptibility to infectious diseases. Is there a relationship? Am J Dis Child. 145:750–754.
Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG, Sarfati M. 1998. Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine. 16:1415– 1419.
DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K. 2001. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus . Pediatrics. 108:E112.
Dorman JS, McCarthy BJ, O’Leary LA, Koehler AN. 1995. Risk Factors for Insulin-Dependent Diabetes. National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda MD: National